Stockscreener 앱 받기
1.195
4.40%
-0.055
전일 마감가:
$1.25
열려 있는:
$1.2
하루 거래량:
97,820
Relative Volume:
0.96
시가총액:
$121.70M
수익:
$17.85M
순이익/손실:
$-96.93M
주가수익비율:
-0.4831
EPS:
-2.4735
순현금흐름:
$-88.29M
1주 성능:
-11.48%
1개월 성능:
-22.40%
6개월 성능:
-64.59%
1년 성능:
-80.38%
1일 변동 폭
$1.19
$1.22
1주일 범위
$1.235
$1.3788
52주 변동 폭
$1.19
$6.2034
Nyxoah Sa Stock (NYXH) Company Profile
Compare NYXH vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
1.195 | 121.70M | 17.85M | -96.93M | -88.29M | -2.4735 |
ABT
Abbott Laboratories
|
105.01 | 181.71B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.69 | 122.39B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
293.24 | 112.48B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.12 | 63.93B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.93 | 50.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-05-12 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-07-31 | 개시 | H.C. Wainwright | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2022-04-21 | 개시 | Oppenheimer | Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2021-12-21 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-07-28 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Nyxoah Sa 주식(NYXH)의 최신 뉴스
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains? - Zacks Investment Research
Nyxoah (NASDAQ: NYXH) Stock Price, News & Analysis - kalkine.ca
Nyxoah (NYXH) Begins BREATHE Study. Can Real-World Evidence Drive Genio Adoption? - Yahoo Finance
Nyxoah SA Actuals & Estimates (HAM:5YI) - TradingView
Gross profit of Nyxoah SA – HAM:5YI - TradingView
Price to book ratio of Nyxoah SA – HAM:5YI - TradingView
Nyxoah Begins U.S. Post-Approval Study of Genio Sleep Apnea Implant - finance.biggo.com
Cash per share of Nyxoah SA – HAM:5YI - TradingView
Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial - Yahoo Finance
Nyxoah implants first patient in BREATHE study of Genio - Yahoo
Nyxoah Launches Major U.S. Post-Approval Study for Genio Sleep Apnea Device - TipRanks
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System - GlobeNewswire
The trading volume of these stocks is deviating from the norm in today's session. - ChartMill
Nyxoah SA (NYXH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cantor Fitzgerald reiterates Nyxoah stock rating on trial success By Investing.com - Investing.com Canada
Cantor Fitzgerald reiterates Nyxoah stock rating on trial success - Investing.com
Cantor Fitzgerald reiterates Nyxoah stock rating on trial success By Investing.com - Investing.com Nigeria
Cantor Fitzgerald reiterates Nyxoah stock rating on trial success By Investing.com - Investing.com India
Nyxoah stock rises on pivotal trial win for Genio (NYXH:NASDAQ) - Seeking Alpha
Nyxoah stock surges as sleep apnea study hits endpoints By Investing.com - Investing.com India
Nyxoah stock surges as sleep apnea study hits endpoints By Investing.com - Investing.com Canada
Nyxoah stock surges as sleep apnea study hits endpoints By Investing.com - Investing.com Nigeria
Nyxoah stock surges as sleep apnea study hits endpoints By Investing.com - Investing.com South Africa
Nyxoah stock surges as sleep apnea study hits endpoints By Investing.com - Investing.com Australia
Nyxoah stock surges as sleep apnea study hits endpoints By Investing.com - Investing.com UK
NYXH Jumps As ACCCESS Trial Data Reset The Trading Map - timothysykes.com
NYXH Stock Jumps As ACCCESS Trial De‑Risks Sleep Apnea Bet - StocksToTrade
NYXH Stock Pops As ACCCESS Trial Data Fuels Breakout Hopes - timothysykes.com
NYXH Stock Jumps As ACCCESS Trial De-Risks U.S. Growth Story - StocksToTrade
Nyxoah (ENXTBR:NYXH) Stock Forecast & Analyst Predictions - Simply Wall Street
87.7% improved on a measure of oxygen drops during sleep. No device-related serious adverse events were reported. - Stock Titan
Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary - GlobeNewswire
Nyxoah SA (NYXH) Stock Price & News - Syfe
Information on the total number of voting rights and shares - GlobeNewswire
Information on the total number of voting rights and shares - Finansavisen
Nyxoah Updates Share Count and Potential Dilution From Convertible Instruments - TipRanks
Nyxoah (NYXH) Results Versus Estimates: The Available Earnings Metric Delivers a Miss in the Current Update; Market Reaction: The Share Price Sheds 2.74% in the Current UpdateEarnings Power Value - vinanet.vn
Nyxoah (NYXH) Results Versus Estimates: The Available Earnings Metric Delivers a Miss in the Current Update; Market Reaction: The Share Price Sheds 2.74% in the Current UpdateFinancial Data - dars.gov.et
Nyxoah (NYXH) Results Versus Estimates: The Available Earnings Metric Delivers a Miss in the Current Update; Market Reaction: The Share Price Sheds 2.74% in the Current UpdateRevenue Guidance Range - dars.gov.et
Nyxoah (NYXH) Latest: Falls 2.74% to $1.60 in Latest Trading; Price Context: the Current Price Sits Inside the Supplied Technical Range at the CloseIndex Put Call - vinanet.vn
Nyxoah (NYXH) Latest: Falls 2.74% to $1.60 in Latest Trading; Price Context: the Current Price Sits Inside the Supplied Technical Range at the CloseETF AUM Growth - siam.in
Nyxoah (NYXH) Latest: Falls 2.74% to $1.60 in Latest Trading; Price Context: the Current Price Sits Inside the Supplied Technical Range at the CloseNarrow Range Breakout - careplusvn.com
Nyxoah (NYXH) Latest: Falls 2.74% to $1.60 in Latest Trading; Price Context: the Current Price Sits Inside the Supplied Technical Range at the ClosePrice Gap Fill - dars.gov.et
Cantor Fitzgerald cuts Nyxoah stock price target on valuation By Investing.com - Investing.com Nigeria
Cantor Fitzgerald cuts Nyxoah stock price target on valuation - Investing.com
Cantor Fitzgerald cuts Nyxoah stock price target on valuation By Investing.com - Investing.com India
Cantor Fitzgerald cuts Nyxoah stock price target on valuation By Investing.com - Investing.com Canada
Cantor Fitzgerald cuts Nyxoah stock price target on valuation - Investing.com
Cantor Fitzgerald Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price - MarketBeat
Cantor Fitzgerald cuts Nyxoah stock price target on valuation By Investing.com - Investing.com UK
Nyxoah Sa (NYXH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.91%
0.78%
자본화:
|
볼륨(24시간):